EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Modulation of HIF1α/CXCR4 by CDDP, acetazolamide, and salidroside in early lung injury caused by acute high-altitude hypoxia

Fei Wang, Yiman Zhang, Bing Liu, Jia Liu, Baochang Lai, Pu Jia, Junbo Zhang, Qiang Ma, Yan Meng, Ye Zhao, Tana Wuren, Xiaohui Zheng und 2 weitere

European Journal of Pharmacology · 2025

DOI: 10.1016/j.ejphar.2025.178174 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmacology, 2025. Verfasst von Fei Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Peripheral Vascular Diseases, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China; Shaanxi Province Center…. Hauptthemen laut MEDLINE: Hypoxia-Inducible Factor 1, alpha Subunit, Receptors, CXCR4, Glucosides, Phenols. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Xi'an Jiaotong University, Key Research and Development Projects of Shaanxi Province, Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The inflammatory response of pulmonary vascular endothelial cells is critical in the pathogenesis of hypobaric hypoxia-induced acute lung injury. Elucidation of the underlying mechanisms and potential therapeutic interventions is crucial for both medical professionals and individuals exposed to high altitudes. METHODS: A murine model of acute lung injury was established by subjecting mice to hypobaric hypoxia at an altitude equivalent to 6000 m for 8 and 72 h. Histopathological and immunohistochemical analyses were performed using hematoxylin-eosin staining and immunohistochemistry to assess inflammation. Western blotting for Endothelial Nitric Oxide Synthase (eNOS) phosphorylation was used to evaluate endothelial injury. High-throughput RNA sequencing was employed to identify early inflammatory regulators, and the protein expression of Hypoxia inducible factor-1 (HIF1α), C-X-C chemokine receptor 4 (CXCR4) and Phospho-Endothelial Nitric Oxide Synthase (p-eNOS) was examined via western blotting. Additionally, the expression level of CXCR4 and selected cytokines were quantified by real-time Polymerase Chain Reaction. RESULTS: Lung tissues demonstrated marked inflammatory infiltration and lung injury after 8 h of hypobaric hypoxia exposure, peaking at 24 h. HIF1α expression was significantly upregulated at 8 h and gradually decreased thereafter. CXCR4, identified as a target gene of HIF1α, exhibited a similar expression pattern. Preventive treatment with compound Danshen dripping pills, acetazolamide and salidroside accelerated the suppression of HIF1α and CXCR4 expression compared to the natural response following 8 h of hypobaric hypoxia. Furthermore, these agents demonstrated enhanced protective effects against endothelial dysfunction and inflammation. CONCLUSIONS: These findings indicate that the endothelial HIF1α/CXCR4 axis plays a pivotal role in the early phase of hypobaric hypoxia-induced acute lung injury. The downregulation of HIF1α/CXCR4 by compound Danshen dripping pills, acetazolamide and salidroside suggests promising therapeutic strategies for managing acute high-altitude hypoxic lung injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypoxia-Inducible Factor 1, alpha SubunitReceptors, CXCR4GlucosidesPhenolsAcute Lung InjuryAcetazolamideHypoxiaAltitude SicknessAltitudeAnimalsMiceMaleNitric Oxide Synthase Type IIIMice, Inbred C57BLLungDisease Models, Animal

Stichwörter der Autor:innen

CXCR4Early inflammationHIF1αHigh-altitude lung injuryTherapeutic strategies

Substanzen

Hypoxia-Inducible Factor 1, alpha SubunitrhodiolosideReceptors, CXCR4GlucosidesPhenolsCXCR4 protein, mouseHif1a protein, mouseNitric Oxide Synthase Type IIIAcetazolamideNos3 protein, mouse

Autor:innen und Institutionen

  • Department of Peripheral Vascular Diseases, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China; Shaanxi Province Center for Innovation Drug Research, College of Life Sciences, Northwest Uni…
  • Department of Peripheral Vascular Diseases, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China; Cardiovascular Research Center, School of Basic Medical Sciences, Xi'an Jiaotong University,…
  • Cardiovascular Research Center, School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an, 710061, China.
  • Shaanxi Province Center for Innovation Drug Research, College of Life Sciences, Northwest University, Xi'an, 710069, China.
  • Department of Peripheral Vascular Diseases, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China; Department of Cardiovascular Medicine, The First Affiliated Hospital of Xi'an Jiaotong Univer…
  • Research Center of High-Altitude Medicine, School of Medicine, Key Laboratory for Application of High-Altitude Medicine, Qinghai University, Xining, 810016, China.

Förderung

  • Xi'an Jiaotong University
  • Key Research and Development Projects of Shaanxi Province
  • Research and Development

Zitieren

APA

Wang, F., Zhang, Y., Liu, B., Liu, J., Lai, B., Jia, P., Zhang, J., Ma, Q., Meng, Y., Zhao, Y., Wuren, T., Zheng, X., Tian, H., & Yin, Q. (2025). Modulation of HIF1α/CXCR4 by CDDP, acetazolamide, and salidroside in early lung injury caused by acute high-altitude hypoxia. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2025.178174

Vancouver

Wang F, Zhang Y, Liu B, Liu J, Lai B, Jia P, et al. Modulation of HIF1α/CXCR4 by CDDP, acetazolamide, and salidroside in early lung injury caused by acute high-altitude hypoxia. European Journal of Pharmacology. 2025. doi:10.1016/j.ejphar.2025.178174

BibTeX
@article{Wang2025,
  author = {Wang, Fei and Zhang, Yiman and Liu, Bing and Liu, Jia and Lai, Baochang and Jia, Pu and Zhang, Junbo and Ma, Qiang and Meng, Yan and Zhao, Ye and Wuren, Tana and Zheng, Xiaohui and Tian, Hongyan and Yin, Qian},
  title = {Modulation of HIF1α/CXCR4 by CDDP, acetazolamide, and salidroside in early lung injury caused by acute high-altitude hypoxia},
  journal = {European Journal of Pharmacology},
  year = {2025},
  doi = {10.1016/j.ejphar.2025.178174}
}
Kostenlos starten →